Income Statement

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Revenues $ 6,067,853 $ 3,564,120
Cost of revenues, including depreciation 2,555,502 1,617,488
Gross profit 3,512,351 1,946,632
Operating expenses:    
Personnel 737,011 226,779
Marketing and promotion 130,087 293,490
General and administrative 1,439,350 651,059
Total operating expenses 2,306,448 1,171,328
Operating income 1,205,903 775,304
Non-operating expenses:    
Interest expense, net 511,519 290,833
Equity compensation 1,078,253 163,574
Loss on debt settlements, net 645,193
Unrealized gain on trading securities (268)
Total non-operating expenses 2,234,965 454,139
Net income (loss) (1,029,062) 321,165
Net income (loss) to noncontrolling interests 165,021 520,017
Net income (loss) attributable to MariMed Inc. $ (1,194,083) $ (198,852)
Net income (loss) per share $ (0.010) $ (0.004)
Weighted average common shares outstanding 116,275,301 52,018,689

Source